Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Miniprotein-Based Therapeutics
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Bristol Myers Squibb
Deal Size : $400.0 million
Deal Type : Collaboration
Bristol Myers Squibb Taps AI Proteins in Drug Discovery Collaboration Worth Up to $400M
Details : Under the collaboration, AI Proteins will leverage its proprietary AI-driven platform to design and optimize novel miniprotein-based therapeutics against targets of interest to Bristol Myers Squibb.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
December 03, 2024
Lead Product(s) : Miniprotein-Based Therapeutics
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Bristol Myers Squibb
Deal Size : $400.0 million
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?